NASDAQ · Healthcare · Biotechnology
BeOne Medicines AG
ONC
BeOne Medicines AG, an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally. CEO John V. Oyler · Market cap $29.9B.
$279.89
+4.55 · +1.65%
52w hi $385.2252w lo $239.25
Off 52w high 31.6%
58
ROUTINE
Current InsiderScore
Corp · 90d
1
0 buys · 1 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
0
0 strong · 0 notable
Analyst consensus
Strong Buy
Avg PT $399.11
Section 01
Recent Form 4 filings
5 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Jun 08 | John Oyler | Chief Executive Officer | Sell | 3,820 | $270.38 | −$1.03M | 58 |
| Nov 17 | Xiaobin Wu | President and COO | Sell | 3,155 | $380.23 | −$1.20M | 47 |
| Nov 13 | Xiaobin Wu | President and COO | Sell | 4,240 | $380.33 | −$1.61M | 47 |
| Nov 12 | Xiaobin Wu | President and COO | Sell | 3,240 | $351.41 | −$1.14M | 34 |
| Nov 12 | Xiaobin Wu | President and COO | Sell | 4,846 | $360.10 | −$1.75M | 38 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JulAugSepOctNovDecJanFebMarAprMayJun